Fax your orders to (877) 471-1327
Contact Us

The trend towards decentralized clinical trials is rapidly growing, providing numerous benefits to patients and trial sponsors. This model allows patients to participate in trials from the comfort of their own homes, reducing the burden of travel and increasing patient engagement and convenience. One of the key components of this new approach is the implementation of mobile phlebotomy, a technology that enables the collection of blood samples from patients in their homes.

 Standardization and Regulation

One of the key challenges in implementing mobile phlebotomy is standardization and regulation. Although this service has been talked about for more than a decade, questions remain on the standardization of the protocols. 

The future strategies would rely on protocol amendments by using compact solutions such as mobile centrifuges and dry ice instead of freezers to allow protocol flexibility. The standardization will take shape routinely once the alternative methods experiment with a few successful trial runs. Thereby, the accuracy and reliability of the blood samples collected are maintained, which is essential for the evaluation of new drugs, treatments, and medical devices.

To address this challenge, it is crucial for industry leaders, regulatory agencies, and healthcare professionals to work together to develop and implement standards and guidelines for the use of mobile phlebotomy. This helps ensure that the technology is used consistently and effectively and that the data collected is high quality.

Improving Patient Safety

Ensuring the safety of patients is a critical aspect of clinical trials. With mobile phlebotomy, there is a risk of contamination of the blood sample if proper sterile techniques are not followed, especially in patient homes. This can impact the accuracy of the data collected and put patients at risk.

To address this challenge, it is important to provide training and education to healthcare professionals performing mobile phlebotomies. The future strategy will make it mandatory to hold remote protocol-specific training to accommodate healthcare professionals from different geographic locations.

Service with Technology Innovation

In the rapidly evolving field of mobile phlebotomy, technology, and innovation will play a crucial role in shaping the future. New tools and technologies are being developed to improve the accuracy, reliability, and safety of mobile phlebotomies. This includes advances in blood collection equipment, as well as the development of new and innovative software solutions for data management and analysis.

Artificial intelligence and machine learning may allow for more sophisticated and automated specimen collection processes in the future. For example, machine learning algorithms could analyze and interpret test results in real-time, allowing quicker and more accurate diagnosis and treatment. There will be more innovations not just in mobile blood drawing but also in customization and status notifications in patient portals for CROs, Sponsors, and Sites. 

The focus for the future as we evolve will focus on one major point of disruption: “Companies with Full-Service capability together with Technology will likely succeed and take over.” By developing and implementing effective strategies to address these challenges, organizations can ensure that they can provide high-quality services to their clients and deliver accurate and reliable patient results.